Objective: To compare the CT findings and iodine concentration between primary gastric lymphoma (PGL) and advanced gastric cancer (AGC), and to evaluate the diagnostic efficacy of dual-source CT in differentiating PGL from AGC. Methods: A total of 50 PGL patients and 50 AGC patients were enrolled. Characteristics of the lesions on CT imaging were recorded, including gastric wall thickness, 'white line' sign of mucosa, sites involved, enhancement degree, and iodine concentration. Results: No significant difference in gastric wall thickness(P=0.874) or sites of stomach involved (P=0.718) were found between PGL and AGC groups. The AGC group had higher positive rate of 'white line' sign of mucosa (64% vs 24%, χ2=16.234, P<0.0001), higher enhancement degree [(45.52±18.0) HU vs (30.72±10.6) HU, P<0.001] and higher iodine concentration [(2.31±0.50) g/mL vs (2.00±0.23) g/mL, P<0.001] than those of PGL group. For diagnosis of AGC, the sensitivity of positive 'white line' sign of mucosa, enhancement ≥34.5 HU and iodine concentration ≥2.25 g/mL were 64%, 76% and 56%, respectively, and the specificity were 76%, 80% and 88%, respectively. Conclusions: The 'white line' sign of mucosa, the enhancement degree, the iodine concentration acquired by dual-source CT are capable of differentiating PGL from AGC. A criterion of iodine concentration ≥2.25 g/mL is recommended for diagnosing AGC. A combined criteria of positive 'white line' sign of mucosa and enhancement ≥34.5 HU in parallel is recommended for the sensitive diagnosis of AGC, with a sensitivity of 90%.
WU Xinyang, ZHANG Huan, PAN Zilai, TAN Jingwen, GAO Xiaoyuan
. The diagnostic value of dual-source CT in differentiating primary gastric lymphoma from advanced gastric cancer[J]. Journal of Diagnostics Concepts & Practice, 2018
, 17(01)
: 60
-65
.
DOI: 10.16150/j.1671-2870.2018.01.011
[1] Doglioni C, Ponzoni M, Ferreri AJ, et al. Gastric lymphoma: the histology report[J]. Dig Liver Dis,2011,43 Suppl 4:S310-S318.
[2] Chang ST, Menias CO.Imaging of primary gastrointestinal lymphoma[J]. Semin Ultrasound CT MR,2013,34(6):558-565.
[3] 冯琦, 庄治国, 许建荣. 胃癌MSCT扫描中征象学改变的初步小结[J]. 中国医学计算机成像杂志,2007,13(2):93-96.
[4] Lee SH, Hur J, Kim YJ, et al.Additional value of dual-energy CT to differentiate between benign and malignant mediastinal tumors: an initial experience[J]. Eur J Radiol,2013,82(11):2043-2049.
[5] Mileto A, Marin D, Alfaro-Cordoba M, et al.Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study[J]. Radiology,2014,273(3):813-820.
[6] Yamauchi H, Buehler M, Goodsitt MM, et al.Dual-Energy CT-Based Differentiation of Benign Posttreatment Changes From Primary or Recurrent Malignancy of the Head and Neck: Comparison of Spectral Hounsfield Units at 40 and 70 keV and Iodine Concentration[J]. Am J Roentgenol,2016,206(3):580-587.
[7] Padhi S, Paul TR, Challa S, et al.Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis[J]. Asian Pac J Cancer Prev,2012,13(10):4889-4895.
[8] Rahman R, Asombang AW, Ibdah JA.Characteristics of gastric cancer in Asia[J]. World J Gastroenterol,2014, 20(16):4483-4490.
[9] Dawson IM, Cornes JS, Morson BC.Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis[J]. Br J Surg,1961,49:80-89.
[10] Wang YG, Zhao LY, Liu CQ, et al.Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases[J]. Medicine (Baltimore),2016,95(31):e4250.
[11] Vitolo U, Seymour JF, Martelli M, et al.Extranodal diffuse large B-cell lymphoma (DLBCL) and primary medias-tinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol,2016,27(Suppl 5):v91-v102.
[12] Mishima Y, Terui Y, Yokoyama M, et al.R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma[J]. Exp Hematol Oncol,2012,1(1):30.
[13] Lee DH, Kim SH, Joo I, et al.CT Perfusion evaluation of gastric cancer: correlation with histologic type[J]. Eur Radiol,2018,28(2):487-495.
[14] 范卫君, 吕衍春, 刘立志, 等. 胃癌和胃淋巴瘤的CT表现对比分析[J]. 癌症,2008,27(5):539-543.
[15] Kerbel RS.Tumor angiogenesis[J]. N Engl J Med,2008, 358(19): 2039-2049.
[16] Barzi A, Thara E.Angiogenesis in esophageal and gastric cancer: a paradigm shift in treatment[J]. Expert Opin Biol Ther,2014,14(9):1319-1332.
[17] Scartozzi M, Giampieri R, Loretelli C, et al.Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients[J]. Pharmacogenomics,2013,14(16):1991-1998.
[18] Tsurumaru D, Miyasaka M, Muraki T, et al.Diffuse-type gastric cancer: specific enhancement pattern on multiphasic contrast-enhanced computed tomography[J]. Jpn J Radiol,2017,35(6):289-295.
[19] Ba-Ssalamah A, Muin D, Schernthaner R, et al.Texture-based classification of different gastric tumors at contrast-enhanced CT[J]. Eur J Radiol,2013,82(10):e537-e543.
[20] Gupta R, Phan CM, Leidecker C, et al.Evaluation of dual-energy CT for differentiating intracerebral hemorrhage from iodinated contrast material staining[J]. Radiology,2010,257(1):205-211.
[21] Brown CL, Hartman RP, Dzyubak OP, et al.Dual-energy CT iodine overlay technique for characterization of renal masses as cyst or solid: a phantom feasibility study[J]. Eur Radiol,2009,19(5):1289-1295.
[22] Apfaltrer P, Meyer M, Meier C, et al.Contrast-enhanced dual-energy CT of gastrointestinal stromal tumors: is iodine-related attenuation a potential indicator of tumor response?[J]. Invest Radiol,2012,47(1):65-70.
[23] Dai X, Schlemmer HP, Schmidt B, et al.Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib[J]. Eur J Radiol,2013,82(2):327-334.
[24] Tang L, Li ZY, Li ZW, et al.Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression[J]. Clin Radiol,2015,70(11):1198-1204.
